1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2015. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html . Accessed 24 Feb 2015.
2. World Health Organization. Chronic obstructive pulmonary disease (COPD): fact sheet no 315. 2015. http://www.who.int/mediacentre/factsheets/fs315/en/#. Accessed 24 Feb 2015.
3. Guarascio AJ, Ray SM, Finch CK, et al. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5(1):235–45.
4. Boehringer Ingelheim International GmbH. Striverdi respimat (olodaterol) inhalation spray for oral inhalation: US prescribing information. 2014. http://www.accessdata.fda.gov . Accessed 24 Feb 2015.
5. Boehringer Ingelheim International GmbH. Striverdi Respimat 2.5 microgram, solution for inhalation: EU summary of product characteristics. 2013. http://mri.medagencies.org/Human . Accessed 24 Feb 2015.